scispace - formally typeset
S

Shmuel Fuchs

Researcher at Rabin Medical Center

Publications -  112
Citations -  9075

Shmuel Fuchs is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 38, co-authored 107 publications receiving 8691 citations. Previous affiliations of Shmuel Fuchs include Beth Israel Deaconess Medical Center & MedStar Washington Hospital Center.

Papers
More filters
Journal ArticleDOI

Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms

TL;DR: In this article, the full spectrum of cytokine genes expressed by marrow stromal cells (MSCs) were characterized using Affymetrix GeneChips representing 12 000 genes.
Journal ArticleDOI

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.

TL;DR: MSC injection improved limb function and appearance, reduced the incidence of auto-amputation, and attenuated muscle atrophy and fibrosis, suggesting MSCs can contribute to collateral remodeling through paracrine mechanisms.
Journal ArticleDOI

The impact of obesity on the short-term andlong-term outcomes after percutaneous coronary intervention: the obesity paradox?

TL;DR: In patients with known CAD who undergo PCI, very lean patients (BMI <18.5) and those with BMI within the normal range are at the highest risk for in-hospital complications and cardiac death and for increased one-year mortality.
Journal ArticleDOI

Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions

TL;DR: Periprocedural major bleeding occurs relatively frequently and is associated with adverse outcomes, and patients >80 years of age who experience intraprocedural complications are at particularly high risk.
Journal ArticleDOI

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia.

TL;DR: Bone marrow cells secrete angiogenic factors that induce endothelial cell proliferation and, when injected transendocardially, augment collateral perfusion and myocardial function in ischemic myocardium.